Las Vegas, Nevada, United States Thynk Capital, LLC. appeared to be the VC, which was created in 2011. The main office of represented VC is situated in the Las Vegas. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Thynk Capital, LLC., startups are often financed by Sky Ventures Group, KIZOO, Cormorant Asset Management. The meaningful sponsors for the fund in investment in the same round are Jim Mellon, Bold Capital Partners. In the next rounds fund is usually obtained by Serum Institute of India Pvt. Ltd., Johnson & Johnson Innovation u2013 JJDC, Jim Mellon.
Among the most popular portfolio startups of the fund, we may highlight X4 Pharmaceuticals, Vedantra Pharmaceuticals, KitoTech Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The fund was created by Jim Plante. Besides them, we counted 1 critical employee of this fund in our database.
The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018. Deals in the range of 5 - 10 millions dollars are the general things for fund. Opposing the other organizations, this Thynk Capital, LLC. works on 22 percentage points less the average amount of lead investments.
Related Funds
| Fund Name | Location |
| Altus Capital Partners | Connecticut, United States, Wilton |
| AXA Investment Managers | France, Ile-de-France, Puteaux |
| BRC Investments | Connecticut, United States, Westport |
| CC Private Equity Partners | - |
| Contento BPS | - |
| Cowtown Angels | Fort Worth, Texas, United States |
| Groupe ADP | France, Ile-de-France, Paris |
| Koubei | China, Hangzhou, Zhejiang |
| Lee Prize for Innovation and Entrepreneurship | Las Vegas, Nevada, United States |
| Madison River Ventures | Chapel Hill, North Carolina, United States |
| Neixiang Fund | - |
| Radicle Capital | Kentucky, Louisville, United States |
| Raine Ventures | California, San Francisco, United States |
| Saifu Momentum Investment | China, Guangdong, Shenzhen |
| Silicon Badia | New York, New York, United States |
| SocialFare | Italy, Piemonte, Torino |
| Supply Chain Ventures | Boston, Massachusetts, United States |
| Trevi Health Ventures | New York, New York, United States |
| Vaux les Ventures | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Intelligent Medicine Exchange | 20 Aug 2021 | - | |||
iviva medical | 05 Mar 2021 | Beverly, Massachusetts, United States | |||
Viscient Biosciences | 30 May 2019 | San Diego, California, United States | |||
Repair Biotechnologies | $2M | 07 May 2019 | Syracuse, New York, United States | ||
X-Vax Technology | 05 Apr 2019 | Florida, United States | |||
Elicio Therapeutics | 06 Nov 2018 | Cambridge, Massachusetts, United States | |||
X4 Pharmaceuticals | 16 Nov 2017 | Cambridge, Massachusetts, United States | |||
Klotho Therapeutics | $10M | 03 Nov 2017 | San Diego, California, United States | ||
Fisker | 15 Sep 2017 | Los Angeles, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Intelligent Medicine Exchange | 20 Aug 2021 | - | |||
iviva medical | 05 Mar 2021 | Beverly, Massachusetts, United States | |||
Viscient Biosciences | 30 May 2019 | San Diego, California, United States | |||
Repair Biotechnologies | $2M | 07 May 2019 | Syracuse, New York, United States | ||
X-Vax Technology | 05 Apr 2019 | Florida, United States | |||
Elicio Therapeutics | 06 Nov 2018 | Cambridge, Massachusetts, United States | |||
X4 Pharmaceuticals | 16 Nov 2017 | Cambridge, Massachusetts, United States | |||
Klotho Therapeutics | $10M | 03 Nov 2017 | San Diego, California, United States | ||
Fisker | 15 Sep 2017 | Los Angeles, California, United States |
